Croda International PLC
Croda offers high-purity multicompendial excipients for topical, parenteral, ophthalmic and oral dosage forms. Featured products include Omega-3 Fatty Acid Concentrates and Super Refined® range of polar and nonpolar excipients.
Website: www.croda.com/healthcare
E-mail: hc-europe@croda.com
Croda International Plc is a UK-based manufacturer and worldwide supplier of oleochemicals offering one of the widest ranges of chemical specialties, surfactants, and high-purity lipids available to the pharmaceutical industry with products manufactured at multiple sites throughout the world.
Croda manufactures excipients of superior quality and purity for the global pharmaceutical market. Croda developed and utilises a proprietary flash chromatographic process called Super Refining™. This process physically removes impurities from pharmaceutical excipients without altering their fundamental structure in any way. This process allows the offering of a range of high purity excipients that can improve API and formulation stability.
Croda offers a complete range of products for topical dosage forms as well as high-purity multicompendial solvents, solubilisers and surfactants suitable for parenteral, oral and ophthalmic formulations. Featured products include Super Refined™ ingredients: Oils, Oleic Acid, Oleyl Alcohol, Isopropyl Myristate, PEGs, Polysorbates, Dimethyl Isosorbide, Medical Grade Lanolins, Poloxamers and Omega 3 Fatty Acid Concentrates.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
